1123
|
MENVEO
|
Meningococcal disease
|
Neisseria meningitidis
|
Inactivated
|
GSK Vaccines
|
Approved
|
Intramuscular
|
NA
|
NA
|
1124
|
Menactra
|
Meningococcal disease
|
Neisseria meningitidis
|
Inactivated
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1125
|
Bexsero
|
Meningococcal disease
|
Neisseria meningitidis
|
Recombinant
|
GSK Vaccines
|
Approved
|
Intramuscular
|
NA
|
NA
|
1126
|
Bexsero (In UK)
|
Meningococcal disease
|
Neisseria meningitidis
|
Recombinant
|
GSK Vaccines
|
Approved
|
Intramuscular
|
NA
|
NA
|
1127
|
TRUMENBA
|
Meningococcal disease
|
Neisseria meningitidis
|
Recombinant
|
Pfizer (Wyeth Pharmaceuticals)
|
Approved
|
Intramuscular
|
NA
|
NA
|
1128
|
MenQuadfi
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1129
|
Menomune
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Sanofi Pasteur Inc.
|
Approved
|
Subcutaneous
|
NA
|
NA
|
1130
|
MenHibrix
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
1131
|
Menitorix
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
1132
|
Nimenrix
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
1133
|
Menjugate
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
GSK Vaccines S.r.l.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1134
|
Meningitec
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Wyeth Pharmaceuticals
|
Approved
|
Intramuscular
|
12675020
|
NA
|
1135
|
Mencevax ACWY
|
Meningococcal disease
|
Neisseria meningitidis
|
Subunit
|
GlaxoSmithKline Biologicals
|
Approved
|
Subcutaneous
|
NA
|
NA
|
1136
|
Quadri Meningo
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Biomed Labs
|
Approved
|
Subcutaneous
|
NA
|
NA
|
1137
|
NEISVAC-C
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
1337
|
Meningo A+C
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT01430611
|
1338
|
Meng Ling Kang
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT01430611
|
1339
|
Walvax MPV ACYW
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Walvax Biotechnology Co., Ltd.
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT04450498
|
1340
|
NmCV-5
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Serum Institute of India Pvt. Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03964012
|
1341
|
MenCC-BIO
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
|
Clinical - Phase 2, Phase 3
|
NA
|
NA
|
NCT02858570
|